New hope for brain bleed victims: Two-Drug combo aims to boost recovery
NCT ID NCT07144956
Summary
This study is testing whether adding a drug called cilostazol to the standard treatment (nimodipine) helps people recover better after a life-threatening brain bleed from a ruptured aneurysm. It will involve 630 adults in France who start treatment within 4 days of their bleed. The main goal is to see if patients have better functional outcomes and independence 6 months later.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEURYSMAL SUBARACHNOID HEMORRHAGE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.